Media Summary: Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath, Daniel J. DeAngelo, MD, PhD, and Nicholas J. Short, MD, discuss ... David Marks, MB, MS, FRACP, PhD, FRCPath, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, discusses the ... Dr. Sanjana Koshy discusses what you need to know about monoclonal

Antibody Therapy In All How - Detailed Analysis & Overview

Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath, Daniel J. DeAngelo, MD, PhD, and Nicholas J. Short, MD, discuss ... David Marks, MB, MS, FRACP, PhD, FRCPath, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, discusses the ... Dr. Sanjana Koshy discusses what you need to know about monoclonal This video contains a detailed and simplified explanation of how monoclonal Usman Ali Akbar, MBBS, University of Louisville, Louisville, KY, talks on the efficacy of monoclonal Francesco Lanza, MD, Ravenna Hospital, Ravenna, Italy, outlines the sequential use of novel monoclonal

In this video, Sara Ghorashian, PhD, MD, FRCP, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK ... At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, ...

Photo Gallery

Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
Advances of antibody therapy in ALL
Monoclonal Antibody Therapy for COVID-19: What Is It and How Does It Work?
What are antibody therapies?
What You Need to Know About Monoclonal Antibody Therapy
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
Monoclonal antibodies for the treatment of adult ALL
How Monoclonal Antibodies Treat Cancer
Monoclonal antibody combinations in ALL
The potential of CAR T-cell therapy in combination with antibodies for the treatment of ALL
New monoclonal antibodies for ALL treatment
Antibody therapeutics overview – monoclonals, bispecifics, ADCs, etc.
Sponsored
Sponsored
View Detailed Profile
Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management

Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management

Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath, Daniel J. DeAngelo, MD, PhD, and Nicholas J. Short, MD, discuss ...

Advances of antibody therapy in ALL

Advances of antibody therapy in ALL

David Marks, MB, MS, FRACP, PhD, FRCPath, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, discusses the ...

Sponsored
Monoclonal Antibody Therapy for COVID-19: What Is It and How Does It Work?

Monoclonal Antibody Therapy for COVID-19: What Is It and How Does It Work?

Monoclonal

What are antibody therapies?

What are antibody therapies?

What are

What You Need to Know About Monoclonal Antibody Therapy

What You Need to Know About Monoclonal Antibody Therapy

Dr. Sanjana Koshy discusses what you need to know about monoclonal

Sponsored
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

This video contains a detailed and simplified explanation of how monoclonal

Monoclonal antibodies for the treatment of adult ALL

Monoclonal antibodies for the treatment of adult ALL

Usman Ali Akbar, MBBS, University of Louisville, Louisville, KY, talks on the efficacy of monoclonal

How Monoclonal Antibodies Treat Cancer

How Monoclonal Antibodies Treat Cancer

How do monoclonal

Monoclonal antibody combinations in ALL

Monoclonal antibody combinations in ALL

Francesco Lanza, MD, Ravenna Hospital, Ravenna, Italy, outlines the sequential use of novel monoclonal

The potential of CAR T-cell therapy in combination with antibodies for the treatment of ALL

The potential of CAR T-cell therapy in combination with antibodies for the treatment of ALL

In this video, Sara Ghorashian, PhD, MD, FRCP, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK ...

New monoclonal antibodies for ALL treatment

New monoclonal antibodies for ALL treatment

At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, ...

Antibody therapeutics overview – monoclonals, bispecifics, ADCs, etc.

Antibody therapeutics overview – monoclonals, bispecifics, ADCs, etc.

Antibodies

What is monoclonal antibody therapy?

What is monoclonal antibody therapy?

What is monoclonal